Clinical Trial Update: A Randomised, Phase II, Comparative Study With a Parallel Control for Evaluating the Efficacy and Safety of Combined Treatment of Lutropin Alpha and Recombinant Human Luteinizing Hormone in the Middle of the Controlled Ovarian Stimulation Follicular Phase in Women With Reduced Ovarian Reserve [Phase 2]

View source ↗

Summary

This Phase II randomized study evaluated the efficacy and safety of combining lutropin alfa with recombinant human LH during the middle of controlled ovarian st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• Luveris (lutropin alfa)
• Recombinant human LH (recombinant human luteinizing hormone)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Infertility, Ovulation Induction | Phase 2 | Status: COMPLETED | Results posted: 2018-03-27